A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study Of PF-04447943 In Subjects With Mild To Moderate Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2012
At a glance
- Drugs PF 4447943 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 13 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2010 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 30 Mar 2010 Planned end date changed from 1 Aug 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History